| 000 | 01701 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514043137.0 | ||
| 264 | 0 | _c20030513 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a1226-3613 | ||
| 024 | 7 |
_a10.1038/emm.2002.30 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeo, Yong-Seok | |
| 245 | 0 | 0 |
_aStructural basis for inhibition of protein tyrosine phosphatases by Keggin compounds phosphomolybdate and phosphotungstate. _h[electronic resource] |
| 260 |
_bExperimental & molecular medicine _cJul 2002 |
||
| 300 |
_a211-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 | _aCatalytic Domain |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aEdetic Acid _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aMolybdenum _xpharmacology |
| 650 | 0 | 4 |
_aPhosphoric Acids _xpharmacology |
| 650 | 0 | 4 | _aProtein Structure, Tertiary |
| 650 | 0 | 4 |
_aProtein Tyrosine Phosphatases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aTungsten Compounds _xpharmacology |
| 700 | 1 | _aRyu, Jung Min | |
| 700 | 1 | _aPark, Sang Myun | |
| 700 | 1 | _aPark, Jeon Han | |
| 700 | 1 | _aLee, Hyung-Chul | |
| 700 | 1 | _aHwang, Kwang Yeon | |
| 700 | 1 | _aKim, Jongsun | |
| 773 | 0 |
_tExperimental & molecular medicine _gvol. 34 _gno. 3 _gp. 211-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/emm.2002.30 _zAvailable from publisher's website |
| 999 |
_c12096743 _d12096743 |
||